Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

FTH holding history

Faeth Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FTH overviewAll 13F holders of FTHFull Q2 2026 holdings

Shares (Q2 2026)
17,329
Value
$433.2K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of FTH by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,329$433.2K<0.1%+8,534+97.0%AddedHolders
Q1 20268,795$277.2K<0.1%+8,785+87,850.0%AddedHolders
Q4 202510$107<0.1%00.0%UnchangedHolders
Q3 202510$95<0.1%00.0%UnchangedHolders
Q2 202510$86<0.1%−451−97.8%ReducedConverted for a 1-for-20 splitHolders
Q1 20259,219$3.63K<0.1%00.0%UnchangedHolders
Q4 20249,219$4.52K<0.1%−3,000−24.6%ReducedHolders
Q3 202412,219$7.31K<0.1%00.0%UnchangedHolders
Q2 202412,219$7.58K<0.1%00.0%UnchangedHolders
Q1 202412,219$12.8K<0.1%+12,000+5,479.5%AddedHolders
Q4 2023219$151<0.1%00.0%UnchangedHolders
Q3 2023219$175<0.1%00.0%UnchangedHolders
Q2 2023219$250<0.1%−128,425−99.8%ReducedHolders
Q1 2023128,644$193.0K<0.1%+128,395+51,564.3%AddedHolders
Q4 2022249$371<0.1%−13,320−98.2%ReducedHolders
Q3 202213,569$21.0K<0.1%−12,606−48.2%ReducedHolders
Q2 202226,175$59.0K<0.1%+15,089+136.1%AddedHolders
Q1 202211,086$25.0K<0.1%−25,760−69.9%ReducedHolders
Q4 202136,846$214.0K<0.1%+33,531+1,011.5%AddedHolders
Q3 20213,315$35.0K<0.1%−104,411−96.9%ReducedHolders
Q2 2021107,726$1.05M<0.1%+101,151+1,538.4%AddedHolders
Q1 20216,575$96.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.